Neos Therapeutics (NEOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,744 | 12,679 | 27,858 | 16,830 | 23,284 |
| Marketable Securities | N/A | N/A | 3,992 | 8,064 | 1,992 |
| Receivables | 20,386 | 17,385 | 20,782 | 26,563 | 28,877 |
| Inventories | 8,436 | 8,730 | 10,218 | 11,010 | 11,676 |
| Other current assets | 0 | 0 | 2,904 | 0 | 1,757 |
| TOTAL | $44,009 | $40,406 | $65,754 | $66,559 | $67,586 |
| Non-Current Assets | |||||
| PPE Net | 5,824 | 6,637 | 7,014 | 7,345 | 7,517 |
| Intangibles | 11,074 | 11,708 | 12,139 | 12,543 | 13,187 |
| Other Non-Current Assets | 3,677 | 3,938 | 4,186 | 4,426 | 3,465 |
| TOTAL | $20,575 | $22,283 | $23,339 | $24,314 | $24,169 |
| Total Assets | $64,584 | $62,689 | $89,093 | $90,873 | $91,755 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 19,472 | 20,096 | 15,534 | 15,836 | 16,108 |
| Accounts payable and accrued liabilities | 8,443 | 9,446 | 13,033 | 6,650 | 6,548 |
| Accrued Expenses | 31,233 | 26,122 | 30,556 | 40,188 | 37,848 |
| TOTAL | $67,161 | $60,860 | $68,399 | $63,355 | $61,142 |
| Non-Current Liabilities | |||||
| Long Term Debt | 13,720 | 13,158 | 29,422 | 29,099 | 28,788 |
| Other Non-Current Liabilities | 4,255 | 4,844 | 4,452 | 4,549 | 4,853 |
| TOTAL | $17,975 | $18,002 | $33,874 | $33,648 | $33,641 |
| Total Liabilities | $85,136 | $78,862 | $102,273 | $97,003 | $94,783 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 49,757 | 49,755 | 49,751 | 49,743 | 49,733 |
| Common Shares | 50 | 50 | 50 | 50 | 50 |
| Retained earnings | -352,254 | -347,343 | -341,835 | -333,885 | -330,397 |
| Other shareholders' equity | -352 | -352 | -351 | -351 | -352 |
| TOTAL | $-20,552 | $-16,173 | $-13,180 | $-6,130 | $-3,028 |
| Total Liabilities And Equity | $64,584 | $62,689 | $89,093 | $90,873 | $91,755 |